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Abstract
Background: The rK39 recombinant protein is derived from a specific antigen produced by the Leishmania donovani
complex, and has been used in the last two decades for the serodiagnosis of visceral leishmaniasis. We present here a
systematic review and meta-analysis of studies evaluating serologic assays to diagnose visceral leishmaniasis to determine
the accuracy of rK39 antigen in comparison to the use of other antigen preparations.
Methodology/Principal Findings: A systematic review with meta-analysis of the literature was performed to compare the
rK39 strip-test and ELISA formats against serological tests using promastigote antigens derived from whole or soluble
parasites for Direct Aglutination Test (DAT), Indirect Immunofluorescence test (IFAT) and ELISA with a promastigote antigen
preparation (p-ELISA). Gold standard diagnosis was defined by the demonstration of amastigotes on hematological
specimens. A database search was performed on Medline, Lilacs, Scopus, Isi Web of Science, and Cochrane Library. Quality of
data was assessed using the QUADAS questionnaire. A search of the electronic databases found 352 papers of which only 14
fulfilled the selection criteria. Three evaluated the rK39 ELISA, while 13 evaluated the rK39 immunochromatographic strip
test. The summarized sensitivity for the rK39-ELISA was 92% followed by IFAT 88% and p-ELISA 87%. The summarized
specificity for the three diagnostic tests was 81%, 90%, and 77%. Studies comparing the rK39 strip test with DAT found a
similar sensitivity of 94%, although the DAT had a slightly higher specificity. The rK39 strip test was more sensitive and
specific than the IFAT and p-ELISA. We did not detect any difference in the sensitivity and specificity between strips
produced by different manufacturers.
Conclusions: The rK39 protein used either in a strip test or in an ELISA, and the DAT are the best choices for implementation
of rapid, easy and efficient test for serodiagnosis of VL.
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Introduction
Visceral Leishmaniasis (VL) is a neglected tropical disease for
which a simple and quick diagnostic test is available, but not yet
widely implemented in rural areas [1]. Although several different
serodiagnostic test formats exist, many of them have not been
validated in prospective field studies [2]. In addition, only a limited
number of well conducted trials comparing the different types of
tests have been published [2]. This lack of data has limited the
routine use of these tests in many settings.
The optimal test for serologic diagnosis is one that is easy to use,
cheap to make, and has both a high sensitivity and specificity. The
use of crude antigens for the serodiagnosis of tropical diseases is
often limited by the difficulty in producing large quantities of the
antigen, and therefore can be difficult to make in a standardized
manner. However, once a useful diagnostic antigen has been
identified, modern molecular biology techniques allow the antigen
to be manufactured as a recombinant protein in a standardized
manner with an advantage over crude lysate undefined antigen
used in DAT. In the recent past, numerous recombinant antigens
have become available for use in serodiagnostic testing of
leishmaniasis [3]. Molecular diagnostic assays for leishmaniasis
using polymerase chain reaction (PCR) targeting multi-copy genes,
(e.g., rRNA, kinetoplastDNA (kDNA) minicircles) have been
developed. Sensitivity and specificity of these tests depend upon
the region targeted, with a recent study finding a peripheral blood
PCR assay having an overall sensitivity of 98.5% [4]. However,
nucleic acid testing is currently difficult to perform in many clinical
labs in the developing world.
The currently available serodiagnostic tests for VL have been
based on four major formats: Direct agglutination (DAT), indirect
immunofluorescence (IFAT), ELISA and immunocromatography
www.plosntds.org 1 January 2012 | Volume 6 | Issue 1 | e1484[3,5,6]. The DAT and IFAT classically utilize whole promastigotes
to screen for antibodies, while the p-ELISA uses a crude lysate of
promastigotes. Immunochromatographic tests, and a newer
ELISA have been developed using the recombinant protein
rK39, which is a kinesin-like gene found in Leishmania chagasi.
Recently, the WHO Special Program for Research and Training
in Tropical Disease (TDR) evaluated five different immunochro-
matographic tests utilizing either rK39 or rKE16, a recombinant
protein developed from the kinesin gene of a Leishmania donovoni
isolate [7]. Testing was performed in East Africa, Brazil and on the
Indian subcontinent, and sensitivities ranged from 36.8–100% and
specificities from 90.8–100%. No test was the clear winner across
all regions and conditions. In addition, since comparisons between
different test types are limited, it remains unclear even which type
of serologic test is most optimal for use in the diagnosis of VL.
Meta-analyses are excellent tools to evaluate multiple studies
with similar goals but varying methods [8]. We performed a meta-
analysis of studies evaluating serodiagnostic tests for VL to
determine the accuracy of rK39 antigen based serodiagnostic
tests in comparison to other available serodiagnostic tests for the
diagnosis of VL.
Methods
Design of study
This is a systematic review of the literature using the Cochrane
recommendations to compare the sensitivity and specificity of
serodiagnostic tests using rK39 antigen in the ELISA and strip test
formats against crude lysate Leishmania antigen used in an ELISA or
whole promastigote parasite as antigen used in DAT and IFAT.
Three hundred fifty-two papers have been published to date
evaluating the rK39 antigen as diagnostic tool for serodiagnosis of
VL. Within these reports, significant discrepancies in sensitivity and
specificity are found, likely due to a multitude of reasons including:
variability in testing methods, testing performed in different
geographic regions, different sources for the tests, and lack of
homogeneity of the studied population. Applying the selection
criteria described below, we included 14studiesinthismeta-analysis.
Inclusion criteria were: a) have a full description of accuracy of
the diagnostic test, b) that were performed on human specimens,
c) include a rK39 antigen based test, d) direct demonstration of
Leishmania parasites as the confirmatory diagnostic method for
VL.
Exclusion criteria were: a) insufficient primary and/or second-
ary data information of (lack information about sensitivity and
specificity), b) lack of inclusion of a control group, c) inclusion of
co-infections with HIV, d) inclusion of subjects that were receiving
or had received VL treatment, e) full text article unavailable, f)
written in a language other than English, Spanish and Portuguese.
Figure 1 describes the process utilized for selection of studies for
the meta-analysis.
Source of data
Data were obtained by a search of the published literature cited
in Medline, Lilacs, Scopus, Isis Web of Science, Cochrane Library accessed
on June 1, 2011.
Search strategy
Our search strategy utilized the following key words: rK39
antigen, Visceral Leishmaniasis, parasitology, accuracy test and
human. We also utilized the suggested synonymous terms for our
search. i) Initial screening of manuscripts was performed by
selecting those with titles related to our subject of study ii) Each
manuscript selected by title then had its abstract reviewed for
inclusion or exclusion based upon the variables reported in the
results. iii) Selected studies the had the full text reviewed to
collect existing primary variables of true positive and false
positive, true negative and false negative data presented in each
study that allowed re-calculation of sensitivities and specificities,
likelihood, predictive values and confidence intervals. Also,
careful reviews of the references in each selected manuscript
were performed to rescue those not selected by search strategy.
This literature review was performed by two independent
reviewers. If the reviewers were in consensus, the manuscript
was accepted for the meta-analysis, if there was disagreement, a
third reviewer was consulted. The QUADAS (Quality in Diagnostic
Accuracy Studies) protocol was used to evaluate the quality of each
study [9].
Statistic analysis
Receiver operating characteristic (ROC) plot were constructed
using the R Statistical Software package.
Results
Our initial electronic search identified 352 articles that were
related to the serodiagnosis of leishmaniasis. Filtering these articles
to those of interest to us, focusing on human studies of rK39, the
list was narrowed to143 studies. Among these, only 50 evaluated
the sensitivity and/or specificity of serodiagnostic testing for VL.
Finally, 40 of these studies were excluded due to duplicity (same
study found in different sources), inclusion of subjects with HIV/
Leishmania co-infection, study of cutaneous leishmaniasis, lack of
evaluation of at least one of the diagnostic tests of interest, and
evaluation of subjects that were already treated or in treatment.
We included an additional four articles after a review of references
from our selected articles.
Description of selected studies
A total of 5,548 individuals were included into the meta-analysis
from the 14 included studies: 2,097 cases of VL and 3,451
controls. The distribution of studies according to region was as
Author Summary
Visceral Leishmaniasis (VL) is a neglected tropical disease
for which serodiagnostic tests are available, but not yet
widely implemented in rural areas. The rK39 recombinant
protein is derived from a kinesin-like protein of parasites
belonging to the Leishmania donovani complex, and has
been used in the last two decades for the serodiagnosis of
VL. We present here a systematic review and meta-analysis
of studies evaluating serologic assays (rK39 strip-test, rK39
ELISA, Direct Agglutination Test [DAT], Indirect Immuno-
fluorescence test [IFAT] and ELISA with a promastigote
antigen preparation [p-ELISA]) to diagnose VL to deter-
mine the accuracy of rK39 antigen in comparison to the
use of other antigen preparations. Fourteen papers
fulfilled the inclusion and exclusion selection criteria. The
summarized sensitivity for the rK39-ELISA was 92%
followed by IFAT 88% and p-ELISA 87%. The summarized
specificity for the three diagnostic tests was 81%, 90%, and
77%. Studies comparing the rK39 strip test with DAT found
a similar sensitivity (94%) and specificity (89%). However,
the rK39 strip test was more specific than the IFAT and p-
ELISA. In conclusion, we found the rK39 protein used either
in a strip test or in an ELISA is a good choice for the
serodiagnosis of VL.
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www.plosntds.org 2 January 2012 | Volume 6 | Issue 1 | e1484follows: Brazil (n=5); Indian (n=4); Nepal (n=2); Tunis, Italy,
and Kuwait (n=1 each). The manuscripts were published during
the period between 1998 to 2011. Thirteen studies reported results
of strip tests: Sundar 1998 [10], Sundar 2007 [11], Saghrouni
2009 [12], Romero 2009 [13], Mathur 2005 [14], Mandal 2008
[15], Iqbal 2002 [16], de Assis 2008 [17], de Assis 2011 [18],
Chappuis 2003 [19], Carvalho 2003 [20], Brandonisio 2002 [21],
and Boelaert 2004 [22]. Three reported results with the rk39-
ELISA: de Assis 2008 [17], Pedras 2008 [23] and Romero 2009
[13]. IFAT results were reported from seven studies Boelaert 2004
[22], Brandonisio 2002 [21], de Assis 2008 [17], Iqbal 2002 [16],
Pedras 2008 [23], Romero 2009 [13] and Saghrouni 2009 [12];
ELISA with crude promastigote lysate results were reported from
six studies: Carvalho 2003 [20], de Assis 2008 [17], Mathur 2005
[14], Pedras 2008 [23], Romero 2009 [13], and Mandal 2008
[15]; and finally DAT results were reported from six studies:
Boelaert 2004 [22], Chappuis 2003 [19], Pedras 2008 [23],
Sundar 2007 [11], de Assis 2011 [18], and Mandal 2008 [15].
A total of 12 studies fulfilled equal or greater than 10 questions
from the 14 QUADAS questions. The studies of Brandonisio 2002
[21] and Mandal 2008 [15] fulfilled 8 and 7 questions respectively.
Measurement of accuracy
The summarized sensitivity of the 13 studies evaluating the
rK39 antigen strip test was 92% [91.49–92.92] and the
summarized specificity was 95% [94.30–95.48]. The likelihood
ratio of a positive test (LR+) was found to be 18.042 [18.03–18.06]
and the likelihood ratio of a negative test (LR2) was found to be
0.082 [20.13–0.29].
These 13 studies were stratified according to which technique
were compared. i) Five studies compared the strip test vs p-ELISA:
Carvalho 2003 [20], de Assis 2008 [17], Mathur 2005 [14],
Romero 2009 [13] and Mandal 2008 [15]; ii) five compared the
strip test vs DAT: Boelaert 2004 [22], Chappuis 2003 [19], Sundar
2007 [11], de Assis 2011 [18], Mandal 2008 [15]; and iii) six
compared the strip test vs IFAT: Boelaert 2004 [22], Brandonisio
Figure 1. Algorithm for selection of studies.
doi:10.1371/journal.pntd.0001484.g001
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and Saghrouni 2009 [12].
Figure 2 demonstrates the ROC plot for comparison of
sensitivity and specificity of the strip test and other test formats.
The ROC plot for the strip test vs p-ELISA demonstrating a
sensitivity, specificity and a positive likelihood ratio (LR+) of 93%,
96%, and 21.16 for the strip test and 88%, 79%, and 4.14 for p-
ELISA, respectively. The study by Romero et al had sensitivity
and specificity values that were quite different from the other
studies (sensitivity of 50% and specificity of 77%). The exclusion of
the Romero study for ROC analysis increased the specificity of
strip test 99% and (LR+) to 68.77, but did not alter the sensitivity,
and increased the sensitivity to 91%, specificity 88%, (LR+) to 7.81
for the p-ELISA. ROC plots for the strip test vs. DAT
demonstrated that the sensitivities and specificities were very close
for both tests (94.23%, 89.97% and LR+ 9.39 for DAT and
94.48% and 88.75% and LR+ 8.40 for the strip test). The ROC
plot comparison of the strip test vs. IFAT revealed a better
performance of strip test than IFAT with a sensitivity, specificity
and LR+ of 87%, 95% and 16.89 for the strip test vs 84%, 92%
and 10.01 for the IFAT. Only two studies compared the strip test
vs. the rK39-ELISA: de Assis 2011 [18] and Romero 2009 [13].
The summarized sensitivity of the tests were similar (93% for both)
and the specificity of each test was 95% and 80% respectively.
This resulted in a higher LR+ for the strip test than the rK39-
ELISA (19.24 vs. 4.61 respectively).
Only three studies evaluated the rK39 antigen used in the
ELISA format: de Assis 2011 [18], Pedras 2008 [23] and Romero
2009 [13]. The pooled characteristics of the studies were:
sensitivity of 92%, specificity of 80% and LR+ of 4.73.
Figure 2. ROC plot comparing the performance of the rK39 strip test to serologic techniques utilizing promastigote antigens for
diagnosis of Visceral Leishmaniasis.
doi:10.1371/journal.pntd.0001484.g002
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presented in figure 3. Summarized sensitivity results for the three
tests are 92%, 87% and 88% and summarized specificity results
are 81%, 77% and 90% respectively. However, evaluation of the
Romero study [13] noted discrepancies between the raw data and
in the sensitivity and confidence intervals (Table 1). The ROC
plot constructed excluding Romero’s study is presented in
figure 2B.
Analysis of heterogeneity of the study
From the thirteen studies that utilized the strip test format,
nine used the Kalazar Detect
TM Test for VL manufactured by
Inbios (Seattle, USA): Sundar 2007 [11], Saghrouni 2009 [12],
Romero 2009 [13], Mathur 2005 [14], Mandal 2008 [15],
Chappuis 2003 [19], Carvalho 2003 [20], Brandonisio 2002
[21], and Boelaert 2004 [22]. Two studies used DiaMed-IT’s
Leish: de Assis 2008 [17], de Assis 2011 [18]; one study used the
Leishmania rapid test strip-test from Intersep: Iqbal 2002 [16];
and one study the recombinant K39 strip test from Arista
Biologicals: Sundar 1998 [10]. The best performances in a single
study for a strip test were demonstrated with the recombinant
K39 strip test from Arista Biologicals, followed by the strip test
from Inbios. However, there was considerable variability in the
results from the studies conducted with the Inbios strip test.
Some of the variability in sensitivity and specificity has been
shown to be associated with the geographic region where the test
is being performed [7]. The best receiver operating characteristic
(ROC) plot for the Inbios strip test was demonstrated by the
results of Brandonisio 2002 [21] who evaluated the test in Italy
(Figure 4).
Comparison by source of Leishmania antigens and tests
details
Three studies evaluated a p-ELISA using L. chagasi promastigotes
as the source ofantigen: Carvalho 2003 [20] de Assis 2008 [17], and
Pedras, 2008 [23]; two studies used L. infantum: Mathur 2005 [14],
Mandal 2008 [15]: and one study L. amazonensis: Romero2009 [13].
The ROC plot was better for the studies that used L. infantum with
the relative order of L. infantum.L. chagasi.L. amazonensis.
Cut off dilution for a positive test on DAT varies from 1:800 to
1:6400. The ROC plot demonstrated that the order of dilutions
was 1:800.1:1600.1:3200.1:6400. For IFAT the cut off
dilution varies from 1:32 to 1:400, ROC plot demonstrated that
the order of dilutions was 1:400.1:160.1:80.1:40.1:32.
Discussion
This meta-analysis utilized rigorous selection criteria to select
published papers that compared four different serodiagnositic tests
currently being utilized in endemic areas for serodiagnosis of VL.
We found that recombinant K39 protein used either in a strip test
or ELISA format and the DAT using whole promastigote antigen
are the most accurate tests for serodiagnosis of VL.
During the past 70 years where various strategies have been
used for the serodiagnosis of VL, there have been waves of
enthusiasm favoring one technique over others [24,25]. The
formol-gel test (FGT) based on gelling and opacification of the
serum from a patient with VL in the presence of formaldehyde was
the only bedside test available in earlier days of last century to
confirm a diagnosis of VL in patients suspected to have Kala-azar
[22]. Early on it was discovered that high levels of specific
Figure 3. ROC plot comparing the performance of the rK39-ELISA to the p-ELISA and IFAT for the diagnosis of Visceral
Leishmaniasis. (A) Analysis including all studies that met our selection criteria. (B) Analysis after removal of the outlier study.
doi:10.1371/journal.pntd.0001484.g003
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activation classified VL as one of the few diseases resembling
multiple myeloma because of the high levels of globulins found in
patients’ serum [26]. This property of VL allowed for the
development of serodiagnostic tests such as the DAT. The DAT
easily can detect high titers up to or higher 1/64.000 dilution folds
in a serum of most VL patients [27], and there are many
comparative studies that have demonstrated that DAT is a good
option to help physicians in endemic areas to confirm the diagnosis
of VL in patients with suggestive symptoms, and when
examination for Leishmania parasites in a bone marrow or spleen
aspirate biopsies is not available [5,6,28,29,30]. Why has the DAT
not been developed into an affordable commercial test available
for use in endemic areas? The WHO attempted to push the
development of such a test in the early 1990s, but was not
successful due to the following reasons: 1) an essential part of the
test is the growth of parasites, and the variability in the techniques
and preservation of the antigen can lead to variation in test results
and 2) high levels of cross reactivity with other trypanosomatides
exist [6,31,32,33,34,35]. The IFAT for VL is a very sensitive test,
but far from being a diagnostic tool in endemic areas, as it has
similar limitations in terms of antigen preparation, and in addition
requires the use of special microscope equipment [36]. On the
other hand, ELISA has been extensively used for serological
diagnosis in VL. However, the sensitivity and specificity of this test
is variable depending upon the antigen chosen for use [29,35,37].
More recently, third generation tests for the serodiagnosis of VL
have utilized two basic formats: ELISA and immunochromato-
graphy [2,36]. A 2003 comparison of 11 defined recombinant or
synthetic proteins with soluble Leishmania antigen (SLA) in an
ELISA format revealed that the best antigen was rK39 with 100%
sensitivity and 97% specificity in the diagnosis of VL [38]. The
recombinant protein K39 (rK39) is a repeated 39-amino acid
sequence derived from a gene cloned from L. chagasi and expressed
in E. coli. The protein is related to the kinesin family of proteins,
has a high epitope density, and is present in high amount in the
amastigotes forms of L. donovani complex [39]. rK39 was first
demonstrated to be an indicator of disease in L. chagasi infected
patients [40]. More recently, the rK39 antigen has been developed
into a strip test for the serodiagnosis of VL [10,19,41,42,43].
Table 1. Comparison of the sensitivity, specificity and likelihood ratio of tests.
Comparison n Test Summary measures
S%[CI] Sp%[CI] LR+[CI] LR2[CI]
Strip test vs p-ELISA 5 Strip test 92.89 [91.85–93.93] 95.61 [94.78–96.44] 21.16 [21.14–21-19] 0.07 [20.32–0.47]
p-ELISA 87.62 [86.28–88.95] 78.86 [77.21–80.52] 4.14 [4.10–4.19] 0.16 [20.11–0.43]
4* Strip test 93.25 [91.53–94.97] 98.64 [97.85–99.44] 68.77 [68.74–68.80] 0.07 [20.64–0.78]
p-ELISA 91.14 [89.20–93.09] 88.32 [86.13–90.52] 7.81 [7.76–7.86] 0.10 [20.34–0.54]
Strip test vs DAT 5 Strip test 94.48 [93.29–95.67] 88.75 [87.11–90.40] 8.40 [8.37–8.43] 0.06 [21.03–1.15]
DAT 94.23 [93.01–95.45] 89.97 [88.40–91.53] 9.39 [9.36–9.42] 0.06 [20.30–0.43]
Strip test vs IFAT 6 Strip test 88.60 [87.56–89.65] 94.75 [94.02–95.49] 16.89 [16.87–16.91] 0.12 [20.12–0.36]
IFAT 83.76 [82.55–84.97] 91.63 [90.72–92.54] 10.01 [9.98–10.04] 0.18 [20.01–0.37]
rK39-ELISA vs p-ELISA vs IFAT 3 rK39-ELISA 91.99 [90.81–93.17] 80.55 [78.83–82.27] 4.73 [4.69–4.77] 0.10 [20.28–0.47]
p-ELISA 86.94 [85.48–88.41] 77.03 [75.20–78.85] 3.78 [3.74–3.83] 0.17 [20.12–0.46]
IFAT 88.43 [87.04–89.82] 89.72 [88.40–91.04] 8.60 [8.56–8.64] 0.13 [20.20–0.46]
2* rK39-ELISA 94.68 [92.77–96.60] 87.50 [84.67–90.33] 7.57 [7.52–7.63] 0.06 [20.53–0.65]
p-ELISA 91.36 [88.96–93.77] 79.02 [75.53–82.50] 4.3 [4.28–4.43] 0.11 [20.34–0.56]
IFAT 89.04 [86.36–91.71] 82.14 [78.87–85.42] 4.99 [4.91–5.06] 0.13 [20.29–0.56]
rK39-ELISA vs Strip test 2 rK39-ELISA 93.17 [92.02–94.32] 79.77 [77.94–81.61] 4.61 [4.56–4.65] 0.09 [20.38–0.55]
Strip test 92.77 [91.59–93.95] 95.18 [94.20–96.16] 19.24 [19.20–19.28] 0.08 [0.04–0.57]
p-ELISA=enzyme immunoassay with antigens of promastigotes of Leishmania sp. DAT=direct agglutination test, IFAT=indirect immunofluorescence; rK39-
ELISA=enzyme immunoassay with rK39 antigen, n=number of studies included in the analysis, S=sensitivity, Sp=specificity; LR+=positive likelihood ratio,
LR2=negative likelihood ratio. CI=confidence interval.
*Analysis in which the study by Romero et al. was excluded because of discrepancies noted in the published data.
doi:10.1371/journal.pntd.0001484.t001
Figure 4. ROC plot showing the heterogeneity of strip test by
continent.
doi:10.1371/journal.pntd.0001484.g004
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issues arise. The DAT has the ability to detect low levels of
antibodies due to the mosaic of antigens present in the extract.
This sensitivity can come at a cost in specificity, as some of these
antigens are cross reactive, and therefore careful attention needs to
be placed on determining the cut-off values for a positive test [44].
Strip tests also have limitations, as with other serologic tests,
patients can have antibody present for months after cure of
disease, and also the tests can detect antibodies in the sera of
asymptomatic patients [24]. False negative results have been
reported and may vary from location to location [36]. In this
review, 154 out of 1884 stored samples from clinically ill patients
with positive amastigotes in bone marrow aspirate did not react
with the strip test. This finding could potentially be explained by
variations in sample storage protocols [45].
A previous meta-analysis comparing the DAT and strip test
including 30 papers evaluating the DAT 13 evaluating the rK39
strip found that tests are comparable. The DAT was found to be
1% most sensitive and 2% more specific than strip test, but this
analysis did not report ROC comparison of sensitivity and
specificity because not all studies selected performed both
techniques [46]. One important criteria of our meta-analysis
study was the inclusion of only studies that compared both
methods in each individual study. In addition our meta-analysis
included comparison of ELISA and IFAT. In our study the best
performance of the strip test were from those studies carried out in
Europe, different from Chappuis’s meta-analysis which found that
sensitivity seemed higher and more homogenous in studies carried
out in South Asia [46].
A newly developed assay based on the detection of antibodies to
the rk28 fusion protein reported a very promising sensitivity and
specificity (96% and 98% respectively) of ELISA to detect anti-
Leishmania antibody in sera from VL patients. However, both the
rK39 and rK28 antigens demonstrated similar areas under the
ROC curves [47,48].
Meta-analysis is an important tool that drives direction for best
evidences in medicine by comparing studies done in different
places, environments and populations as long as the same question
was used by different investigators. But, unfortunately when we
focus the meta-analysis on sensitivities and specificities of
serological tests the heterogeneity introduced by variations in
diagnostic thresholds becomes an important limitation of this
analytic tool [49]. We suggest that investigators in endemic areas
should consider using both rK39 strip test and DAT prior to
initiating anti-Leishmania treatment when demonstration of the
parasite in bone marrow or spleen aspirate biopsies is not
available.
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